Also, to analyze the gene expression of additional molecules regulated by SETD310,22,29–32 that could potentially explain the differences between the prognostic impact on diverse breast cancer subtypes, we also quantified MMP-2, KLC4, iNOS and eNOS mRNA levels in MCF-7 and MDA-MB-231 cells. The gene discussed is NOS2; the disease is breast carcinoma.